Stemgent

Stemgent

Stemgent is an American privately funded biotech company focused on providing reagents and technology developed by some of the worlds leading stem cell scientists. Founded in 2008, Stemgent has two fully operational facilities in both San Diego, California and Cambridge, Massachusetts. Wikipedia

Stemgent

Stemgent is an American privately funded biotech company focused on providing reagents and technology developed by some of the worlds leading stem cell scientists. Founded in 2008, Stemgent has two fully operational facilities in both San Diego, California and Cambridge, Massachusetts. Wikipedia

  • Apr 19 at 6:48 PM
    See our Interactive April eNewsletter @ http://bit.ly/1q6Zpxu and learn about our new advances in innovative technology!
  • Apr 5 at 1:39 PM
    http://bit.ly/1YddhSa Generation of clinically compatible and genetically stable iPS cell lines from human peripheral and cord blood using microRNA-facilitated srRNA reprogramming - Expert Brad Hamilton Presenting in Tel Aviv at IsraStem 2016 !
  • Feb 12 at 4:07 PM
    Evolve Your iPS Reprogramming to Virus-free, Non-integrating RNA-based Reprogramming http://bit.ly/1Qc0LTm
  • Feb 1 at 6:57 PM
    Join us @ISSCR2016 Dresden Feb. 1-3 for to see our latest technologies to help expand your research. Sarah Eminli-Meissner presents 2 insightful posters: http://bit.ly/1QBOiVQ A novel four transfection protocol for deriving iPS cell lines from human blood-derived endothelial progenitor cells (EPCs) and adult human dermal fibroblasts using a cocktail of non-modified reprogramming and immune evasion mRNA http://bit.ly/1KloJci Generation of Clinically Relevant iPS Cell Lines From Human Peripheral & Cord Blood Derived Endothelial Progenitor Cells UsingSelf-replicative RNA

Apr 19, 6:48 PM

See our Interactive April eNewsletter @ http://bit.ly/1q6Zpxu and learn about our new advances in innovative technology!

Apr 5, 1:39 PM

http://bit.ly/1YddhSa Generation of clinically compatible and genetically stable iPS cell lines from human peripheral and cord blood using microRNA-facilitated srRNA reprogramming - Expert Brad Hamilton Presenting in Tel Aviv at IsraStem 2016 !

Feb 12, 4:07 PM

Evolve Your iPS Reprogramming to Virus-free, Non-integrating RNA-based Reprogramming http://bit.ly/1Qc0LTm

Feb 1, 6:57 PM

Join us @ISSCR2016 Dresden Feb. 1-3 for to see our latest technologies to help expand your research. Sarah Eminli-Meissner presents 2 insightful posters: http://bit.ly/1QBOiVQ A novel four transfection protocol for deriving iPS cell lines from human blood-derived endothelial progenitor cells (EPCs) and adult human dermal fibroblasts using a cocktail of non-modified reprogramming and immune evasion mRNA http://bit.ly/1KloJci Generation of Clinically Relevant iPS Cell Lines From Human Peripheral & Cord Blood Derived Endothelial Progenitor Cells UsingSelf-replicative RNA